EWMCX
Price
$42.80
Change
-$0.21 (-0.49%)
Updated
Jul 13 closing price
Net Assets
534.48M
GFACX
Price
$71.84
Change
-$1.16 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

EWMCX vs GFACX

EWMCX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
EWMCX vs. GFACX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWMCX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 357B vs. EWMCX (534M). EWMCX pays higher dividends than GFACX: EWMCX (0.06) vs GFACX (0.00). EWMCX was incepted earlier than GFACX: EWMCX (81 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than EWMCX (0.90). GFACX is a more actively managed with annual turnover of: 32.00 vs. EWMCX (17.00). GFACX has a lower initial minimum investment than EWMCX: GFACX (250) vs EWMCX (1000). EWMCX annual gain was more profitable for investors over the last year : 12.14 vs. GFACX (1.73). EWMCX return over 5 years is better than : 37.50 vs. GFACX (6.34).
EWMCXGFACXEWMCX / GFACX
Total Expense Ratio0.901.3567%
Annual Report Gross Expense Ratio0.901.3567%
Fund Existence81 years25 years-
Gain YTD9.8316.746146%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets534M357B0%
Annual Yield % from dividends0.060.00-
Returns for 1 year12.141.73703%
Returns for 3 years38.3731.09123%
Returns for 5 years37.506.34592%
Returns for 10 years227.7578.97288%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CABO37.931.74
+4.81%
Cable One
ARHS7.73-0.13
-1.65%
Arhaus
MPWR1291.38-61.36
-4.54%
Monolithic Power Systems
CRSP50.63-2.72
-5.10%
CRISPR Therapeutics AG
CYN1.22-0.07
-5.43%
Cyngn Inc.